Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Beter beeld van pancreascarcinoom dankzij FF-OCT
apr 2017 | Chirurgie, Maag-darm-leveroncologie